1. Home
  2. CTRI vs NKTR Comparison

CTRI vs NKTR Comparison

Compare CTRI & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Centuri Holdings Inc.

CTRI

Centuri Holdings Inc.

N/A

Current Price

$20.54

Market Cap

2.4B

Sector

N/A

ML Signal

N/A

Logo Nektar Therapeutics

NKTR

Nektar Therapeutics

N/A

Current Price

$74.19

Market Cap

2.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CTRI
NKTR
Founded
1909
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.2B
IPO Year
2024
1996

Fundamental Metrics

Financial Performance
Metric
CTRI
NKTR
Price
$20.54
$74.19
Analyst Decision
Hold
Strong Buy
Analyst Count
5
7
Target Price
$29.88
$146.67
AVG Volume (30 Days)
1.5M
472.7K
Earning Date
05-08-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
412.50
N/A
EPS
N/A
N/A
Revenue
$2,982,781,000.00
$307,711,000.00
Revenue This Year
$14.62
N/A
Revenue Next Year
$8.16
N/A
P/E Ratio
N/A
N/A
Revenue Growth
13.10
86.00
52 Week Low
$19.04
$33.40
52 Week High
$42.99
$109.00

Technical Indicators

Market Signals
Indicator
CTRI
NKTR
Relative Strength Index (RSI) 34.34 56.01
Support Level N/A $64.99
Resistance Level $27.72 $76.49
Average True Range (ATR) 0.73 3.07
MACD 0.04 -0.31
Stochastic Oscillator 17.30 71.28

Price Performance

Historical Comparison
CTRI
NKTR

About CTRI Centuri Holdings Inc.

Centuri Holdings Inc is a pure-play North American utility infrastructure services company that partners with regulated utilities to maintain, upgrade and expand the energy network that powers millions of homes and businesses. Its service offerings consist of the modernization of utility infrastructure through the maintenance, retrofitting and installation of electric and natural gas distribution networks to meet current and future demands while also preparing systems for the transition to clean energy sources. Its reportable segments are: (i) U.S. Gas Utility Services (U.S. Gas); (ii) Canadian Utility Services (Canadian Operations); (iii) Union Electric Utility Services (Union Electric); and (iv) Non-Union Electric Utility Services (Non-Union Electric).

About NKTR Nektar Therapeutics

Nektar Therapeutics is a clinical-stage, research-based biopharmaceutical company headquartered in San Francisco, California, and incorporated in Delaware, focused on discovering and developing medicines in the field of immunotherapy. The Company directs its efforts toward creating immunomodulatory agents that selectively induce, amplify, attenuate, or prevent immune responses to achieve desired therapeutic outcomes. Its pipeline of clinical-stage and preclinical-stage immunomodulatory agents targets the treatment of autoimmune diseases, including rezpegaldesleukin, NKTR-0165, NKTR-0166, and NKTR-422, as well as cancer, including NKTR-255.

Share on Social Networks: